Jeffrey L. Vacirca

Jeffrey Vacirca, MD, FACP is a board certified hematologist and oncologist at New York Cancer & Blood Specialists, where he serves as CEO and managing partner. His specialties include breast cancer, prostate cancer, and complicated cancers.

Currently, Dr. Vacirca is the president of the Community Oncology Alliance (COA), medical director for Amerisource Bergen specialty group, a Scientific Advisory Board Member for Caris Life Sciences, president and co-founder of National Translational Research Group, and serves as a medical board advisor for Flatiron Health.

Additionally, he is the vice-chairmen of the board for Odonate Therapeutics, a company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Furthermore, he has joined the Board of Directors for One Oncology, an oncologist-led company providing oncologists with innovative tools to help keep cancer care in the hands of the providers.

Dr. Vacirca received his undergraduate degree from the University at Albany and his medical degree from St. George’s University School of Medicine. He completed his residency in internal medicine along with his fellowships in hematology and medical oncology at Stony Brook University Hospital. In his final year of training, he was named chief fellow.